KIR2DL1 Fc-fusion, Biotin-labeled HiP(tm) Recombinant

BPS Bioscience

KIR2DL1 Fc-fusion, Biotin-labeled HiP(tm) Recombinant

7

Research Use Only

Biotin

KIR2DL1

killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1

CD158A, KIR-K64, KIR221, KIR2DL3, NKAT, NKAT-1, NKAT1, p58.1, killer cell immunoglobulin-like receptor 2DL1, CD158 antigen-like family member A, KIR2DL protein, KIR2DL1/3DL2, MHC class I NK cell receptor, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, killer inhibitory receptor 2-2-1, natural killer-associated transcript 1, p58 NK cell inhibitory receptor NKR-K6, p58 NK receptor CL-42/47.11, p58 killer cell inhibitory receptor KIR-K64, p58 natural killer cell receptor clones CL-42/47.11, p58.1 MHC class-I-specific NK receptor

Killer cell immunoglobulin-like receptor 2DL1

Human KIR2DL1, also known as Killer cell immunoglobulin-like receptor 2DL1, CD158A, or NKAT-1, .GenBank Accession No. NM_014218, a.a. 22-245 fused at the C terminus to the Fc portion of human IgG1 followed by a C-terminal Avi-tag™ and expressed in a HEK293 cell expression system. MW=52 kDa. This protein is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation is confirmed to be ≥90%. This protein runs at a higher MW due to glycosylation.

-80°C

41116100

Human